FDA approves updated labeling for Simponi Aria FDA approves Brilinta 60 mg tablets McKesson public policy forum encourages pharmacists to get involved FDA unveils draft guidance for naming biosimilars E-prescribing controlled substances now legal nationwide FDA approves Synjardy tablets NACDS honors two chains for political advocacy Educating policy-makers to effect Rx change Primary care regains momentum amid innovation States spawn a patchwork of reform rules First Previous 56 57 58 59 60 Next Last
